Why tie up ,000+ in working capital with legacy Japanese converters (Taiki) or Korean mega-manufacturers (Nico Medical)? YANSE COS delivers identical cleanroom GMP standards, L'Oréal/Watsons audit credentials, and in-house substrate converting with an accessible 3,000-unit trial MOQ and 30-day mass delivery.
Send us your current spec or target product for an instant quote.
A transparent look at MOQ, lead times, technological control, and regulatory support.
| Evaluation Parameter | YANSE COS (Specialized Direct OEM) | Legacy Japanese OEMs (e.g. Taiki) | Korean Tier-1 Patch Plants (e.g. Nico) | Generic Trading Companies |
|---|---|---|---|---|
| Trial Order MOQ | ✓ 3,000 units/SKU | ✕ 50,000+ units | ✕ 20,000 – 50,000 units | 5,000 – 10,000 units |
| Production Lead Time | ✓ ~30 Days Mass Lead Time | 90 – 120 Days | 60 – 90 Days | 45 – 60 Days |
| Sampling Speed | ✓ Ready samples in 72h | 3–4 Weeks | 2–3 Weeks | 1–2 Weeks |
| In-House Substrate Control | ✓ Makes Paper, Film & Patches In-House | Paper only (outsources patches) | Hydrocolloid only (outsources paper) | ✕ Outsourced 100% |
| Audits & Certifications | ✓ L'Oréal, Watsons, MINISO, BV ISO 22716 | ✓ ISO 22716, GMP | ✓ ISO 22716, FDA | ✕ Basic trading permit |
| US MoCRA & EU CPNP Support | ✓ Included with complete PIF/CoA | Included (expensive) | Extra regulatory consulting fee | ✕ Minimal/incomplete |
As consumer demand for pimple patches, exfoliating pads, and matte oil control surges globally, single-source reliance on overloaded factories poses severe supply chain risks. Leading beauty conglomerates use YANSE COS as their verified agile secondary partner—deploying pilot runs, regional exclusives, and surge capacity with zero compromise in GMP compliance.
Discuss Second-Source Qualification →